Remifentanil

Remifentanil has been studied in 7 papers since 2016: 5 trials and 1 observational study in people, 1 in animals; 2 in the past year. It is an approved medicine. The newest paper, Apr 1, 2026: “Impact of Anesthetic Techniques on Postoperative Cognitive Dysfunction Following Neurosurgery”.

InterventionApproved 1996

7 papers study it12 more mention it2 findingsUpdated

PubChemChEBIMeSH

See all 19 papers on remifentanil

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country; 128 trials, none about aging, 66 with no results posted.

“The use of remifentanil does not reduce POCD.”
Effect of remifentanil and fentanyl on postoperative cognitive function and cytokines level in elderly patients undergoing major abdominal surgeryJournal of clinical anesthesia2016doi:10.1016/j.jclinane.2016.07.016

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • 128 trials, none about aging, 66 with no results posted
  • Human trial5
  • Humans1
  • Animals1

Studies in people

1 study gave remifentanil to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on postoperative cognitive dysfunction

down: Decreases IL-6P=.04

Randomized trialseventh postoperative day622 peopleolder than 60 yearsOlder adultsJournal of clinical anesthesia, Aug 4, 2016

What did studies of remifentanil find?

2

Studies of remifentanil measured 2 outcomes: IL-6 and postoperative cognitive dysfunction.

IL-6

downin humans1

1 study
  1. Remifentanil decreases IL-6 in humans (compared with fentanyl) (P=.04).

    “IL-6 levels were lower the seventh day after surgery for remifentanil group (P= .04)”

    Human trialcompared with fentanylseventh postoperative day

    Effect of remifentanil and fentanyl on postoperative cognitive function and cytokines level in elderly patients undergoing major abdominal surgery

    Journal of clinical anesthesia

More on IL-6

Postoperative cognitive dysfunction

no changein humans1

1 study
  1. Remifentanil showed no clear effect on postoperative cognitive dysfunction in humans (compared with fentanyl).

    “The use of remifentanil does not reduce POCD.”

    Human trialcompared with fentanyln = 622

    Effect of remifentanil and fentanyl on postoperative cognitive function and cytokines level in elderly patients undergoing major abdominal surgery

    Journal of clinical anesthesia

More on Postoperative cognitive dysfunction

Has remifentanil been tested in people?

0 of 128 about aging

Yes: 5 trials and 1 observational study in people have been published, and 128 trials are registered.

Approved

  • FDA Ultiva

    Jul 12, 1996anesthesia, general anesthesia

Repurposing

40 of 56

In trials

  • Sedation

    Phase 4Completed3 trials

  • Bronchoscopy

    Phase 4Completed2 trials

  • Drug Usage

    Phase 4Completed2 trials

  • Endotracheal Intubation

    Phase 4Completed2 trials

  • Labor Pain

    Phase 4Completed2 trials

  • Pneumoperitoneum

    Phase 4Results posted2 trials

All 19

Stopped

  • NCT00778505TerminatedAnesthesia

    difficulty in recruiting

  • NCT03994146TerminatedPain

    Recruitment rate was not compatible with study completion

  • NCT02664922TerminatedHeart disease

    Poor study design and too many study groups.

  • NCT06312657TerminatedOpioid-related disorders

    Funding ended

Trial sponsors

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 04 papers in 12 months

See all 19 papers on remifentanil